Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Whitehead, Clare ^a   Teh, Wan T ^b   Walker, Susan P ^a   Leung, Cheryl ^b   Mendis, Sonali ^a   Lamour, Luke ^b   Tong, Stephen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Biomarker; Circulating mRNA; Diagnostics; Fetal growth restriction; Fetal hypoxia; Pregnancy

Indexed keywords

LACTIC ACID; MESSENGER RNA;

ACIDEMIA; ADULT; ARTICLE; BIRTH; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; FETUS; FETUS HYPOXIA; GENE EXPRESSION; GENETIC CODE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LABOR INDUCTION; LABOR STAGE 2; LONGITUDINAL STUDY; MATERNAL BLOOD; MICROARRAY ANALYSIS; PH; PREECLAMPSIA; PREGNANT WOMAN; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; UMBILICAL ARTERY;

ADULT; ANOXIA; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; PREGNANCY; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84890125683     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-256     Document Type: Article

References (31)

1. Ross MG. Labor and fetal heart rate decelerations: relation to fetal metabolic acidosis. Clin Obstet Gynecol 2011, 54:74-82.
2. Marsal K. Obstetric management of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009, 23:857-870.
3. Grivell RM, Alfirevic Z, Gyte GM, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database Syst Rev 2010, CD007863.
4. Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2008, CD000038.
5. Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2010, CD007529.
6. Locatelli A, Andreani M, Pizzardi A, Paterlini G, Stoppa P, Ghidini A. Antenatal variables associated with severe adverse neurodevelopmental outcome among neonates born at less than 32 weeks. Eur J Obstet Gynecol Reprod Biol 2010, 152:143-147.
7. Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Müller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007, 109:253-261.
8. Alberry M, Soothill P. Management of fetal growth restriction. Arch Dis Child Fetal Neonatal Ed 2007, 92:F62-F67.
9. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003, 100:4748-4753.
10. Go AT, van Vugt JM, Oudejans CB. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update 2011, 17:372-382.
11. White CR, Doherty DA, Henderson JJ, Kohan R, Newnham JP, Pennell CE. Accurate prediction of hypoxic-ischaemic encephalopathy at delivery: a cohort study. J Matern Fetal Neonatal Med 2012, 25:1653-1659.
12. Wood C, Ng KH, Hounslow D, Benning H. Time-an important variable in normal delivery. J Obstet Gynaecol Br Commonw 1973, 80:295-300.
13. Wood C, Ng KH, Hounslow D, Benning H. The influence of differences of birth times upon fetal condition in normal deliveries. J Obstet Gynaecol Br Commonw 1973, 80:289-294.
14. Humphrey MD, Chang A, Wood EC, Morgan S, Hounslow D. A decrease in fetal pH during the second stage of labour, when conducted in the dorsal position. J Obstet Gynaecol Br Commonw 1974, 81:600-602.
15. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006, 11:317-326.
16. Nicolaides KH, Economides DL, Soothill PW. Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol 1989, 161:996-1001.
17. Nicolaides KH, Bilardo CM, Soothill PW, Campbell S. Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. BMJ 1988, 297:1026-1027.
18. McKinlay CJ, Crowther CA, Middleton P, Harding JE. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am J Obstet Gynecol 2012, 206:187-194.
19. Liggins GC, Grieves SA, Kendall JZ, Knox BS. The physiological roles of progesterone, oestradiol-17 and prostaglandin F 2 in the control of ovine parturition. J Reprod Fertil Suppl 1972, Suppl 16:85-103.
20. Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet 1999, 353:1404-1407.
21. Robertson MC, Murila F, Tong S, Baker LS, Yu VY, Wallace EM. Predicting perinatal outcome through changes in umbilical artery Doppler studies after antenatal corticosteroids in the growth-restricted fetus. Obstet Gynecol 2009, 113:636-640.
22. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999, 319:1054-1059.
23. Okazaki S, Sekizawa A, Purwosunu Y, Farina A, Wibowo N, Okai T. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women. Obstet Gynecol 2007, 110:1130-1136.
24. Paiva P, Whitehead C, Saglam B, Palmer K, Tong S. Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. J Clin Endocrinol Metab 2011, 96:E1807-E1815.
25. Whitehead CL, Walker SP, Mendis S, Lappas M, Tong S. Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction. Am J Obstet Gynecol 2013, 209:133. e.1-9.
26. Whitehead CL, Walker SP, Ye L, Mendis S, Kaitu'u-Lino TJ, Lappas M, Tong S. Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction. J Clin Endocrinol Metab 2013, 98:E429-E436.
27. Sekizawa A, Purwosunu Y, Farina A, Shimizu H, Nakamura M, Wibowo N, Rizzo N, Okai T. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation. BJOG 2010, 117:557-564.
28. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev 2006,:CD006066.
29. Baschat AA, Galan HL, Bhide A, Berg C, Kush ML, Oepkes D, Thilaganathan B, Gembruch U, Harman CR. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet Gynecol 2006, 27:41-47.
30. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009, 24:97-106.
31. Marinoni E, Pacioni K, Sambuchini A, Moscarini M, Letizia C, Di Iorio R. Regulation by hypoxia of adrenomedullin output and expression in human trophoblast cells. Eur J Obstet Gynecol Reprod Biol 2011, 154:146-150.